Core Viewpoint - The company, Brainstorm Cell Therapeutics (脑动极光-B), experienced a significant decline in stock price following the announcement of a share placement, indicating market reaction to the capital raising strategy [1] Group 1: Stock Performance - The stock opened down over 6%, currently trading at 5.97 HKD, reflecting a drop of 6.28% [1] - The trading volume reached 519 million HKD, indicating active market participation [1] Group 2: Share Placement Details - The company plans to place 92 million shares, representing approximately 6.77% of the enlarged share capital [1] - The placement price is set at 5.6 HKD per share, which is about 12.09% lower than the closing price of 6.37 HKD on January 22 [1] - The total capital raised is expected to be 515 million HKD, with a net amount of approximately 501 million HKD after expenses [1] Group 3: Use of Proceeds - Approximately 50% of the net proceeds will be allocated to research and development [1] - About 30% will be used for domestic and international market development [1] - Approximately 10% is earmarked for strategic investments and acquisitions, with another 10% designated for general corporate operational funds [1]
脑动极光-B低开逾6% 拟折让约12%先旧后新配股 净筹约5.01亿港元